Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure.
Marcath LA, Kidwell KM, Robinson AC, Vangipuram K, Burness ML, Griggs JJ, Poznak CV, Schott AF, Hayes DF, Henry NL, Hertz DL.
Marcath LA, et al.
Pharmacogenomics. 2019 Jan;20(2):95-104. doi: 10.2217/pgs-2018-0162. Epub 2018 Dec 6.
Pharmacogenomics. 2019.
PMID: 30520341
Free PMC article.